Next Article in Journal
Sulfasalazine Treatment Suppresses the Formation of HLA-B27 Heavy Chain Homodimer in Patients with Ankylosing Spondylitis
Next Article in Special Issue
Generation of Potent Anti-Vascular Endothelial Growth Factor Neutralizing Antibodies from Mouse Phage Display Library for Cancer Therapy
Previous Article in Journal
Aire-Overexpressing Dendritic Cells Induce Peripheral CD4+ T Cell Tolerance
Previous Article in Special Issue
Mesenchymal Stem Cell-Mediated Effects of Tumor Support or Suppression
Open AccessReview

Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic Perspectives

1
Institute of Microbial Chemistry (BIKAKEN), Numazu, 18-24 Miyamoto, Numazu-shi, Shizuoka 410-0301, Japan
2
Division of Molecular Biotherapy, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan
3
Department of Urology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo 113-8677, Japan
4
Department of Urology, Kashiwa Kousei General Hospital, 617 Shikoda, Kashiwa-shi, Chiba 277-8551, Japan
*
Author to whom correspondence should be addressed.
Academic Editor: William Chi-shing Cho
Int. J. Mol. Sci. 2016, 17(1), 43; https://doi.org/10.3390/ijms17010043
Received: 6 November 2015 / Revised: 14 December 2015 / Accepted: 24 December 2015 / Published: 29 December 2015
(This article belongs to the Collection Advances in Molecular Oncology)
Bladder cancer (BC), the most common cancer arising from the human urinary tract, consists of two major clinicopathological phenotypes: muscle-invasive bladder cancer (MIBC) and non-muscle-invasive bladder cancer (NMIBC). MIBC frequently metastasizes and is associated with an unfavorable prognosis. A certain proportion of patients with metastatic BC can achieve a remission with systemic chemotherapy; however, the disease relapses in most cases. Evidence suggests that MIBC comprises a small population of cancer stem cells (CSCs), which may be resistant to these treatments and may be able to form new tumors in the bladder or other organs. Therefore, the unambiguous identification of bladder CSCs and the development of targeted therapies are urgently needed. Nevertheless, it remains unclear where bladder CSCs originate and how they are generated. We review recent studies on bladder CSCs, specifically focusing on their proposed origin and the possible therapeutic options based on the CSC theory. View Full-Text
Keywords: cancer stem cell; bladder cancer cancer stem cell; bladder cancer
Show Figures

Graphical abstract

MDPI and ACS Style

Ohishi, T.; Koga, F.; Migita, T. Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic Perspectives. Int. J. Mol. Sci. 2016, 17, 43.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop